2024. Study of Levofloxacin and Cefoperazone-Sulbactam Utilization Cost on Patients with Mild and Moderate Corona Virus Disease- 2019: Studi Biaya Penggunaan Antibiotik Levofloxacin dan Cefoperazone-Sulbactam pada Pasien Corona Virus Disease-2019 Derajat Ringan sampai Sedang. Journal Pharmasci (Journal of Pharmacy and Science). 9, 1 (Jun. 2024), 59–63. DOI:https://doi.org/10.53342/pharmasci.v9i1.316.